Ryan Maynard

Ryan Maynard

Director of Finance/CFO presso CARA THERAPEUTICS, INC.

Patrimonio netto: 12 285 $ in data 31/03/2024

54 anni
Health Technology
Technology Services
Electronic Technology

Profilo

Ryan D.
Maynard
is currently serving as the Chief Financial Officer at CARA Therapeutics, Inc. since 2022 and as an Independent Director at Iovance Biotherapeutics, Inc. since 2015.
He also holds the position of Chief Financial Officer at Paulus (Holdings) Ltd.
Additionally, Mr. Maynard has previously worked as the Controller, Director-Finance & Accounting at Personify, Inc. (California) from 1999 to 2001, Senior Manager-Finance at Siliconix, Inc. from 1994 to 1998, Controller at General Magic, Inc. from 1998 to 1999, CFO, Executive VP & Head-Investor Relations at Rigel Pharmaceuticals, Inc. from 2001 to 2017, Chief Financial Officer at Blade Therapeutics, Inc. from 2018 to 2019, and Chief Financial Officer at LetsGetChecked, Inc. from 2019 to 2022.
Mr. Maynard completed his undergraduate degree at Santa Clara University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/02/2024 13 500 ( 0.02% ) 12 285 $ 31/03/2024
01/03/2024 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Ryan Maynard

SocietàPosizioneInizio
IOVANCE BIOTHERAPEUTICS, INC. Director/Board Member 16/02/2015
CARA THERAPEUTICS, INC. Director of Finance/CFO 12/09/2022
Director of Finance/CFO -
Tutte le posizioni attive di Ryan Maynard

Precedenti posizioni note di Ryan Maynard

SocietàPosizioneFine
Director of Finance/CFO 01/03/2022
Director of Finance/CFO 01/06/2019
RIGEL PHARMACEUTICALS, INC. Director of Finance/CFO 31/12/2017
Director of Finance/CFO 01/04/2001
GENERAL MAGIC, INC. Comptroller/Controller/Auditor 01/10/1999
Vedi nel dettaglio l'esperienza di Ryan Maynard

Formazione di Ryan Maynard

Santa Clara University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ryan Maynard

Relazioni

94

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
RIGEL PHARMACEUTICALS, INC.

Health Technology

CARA THERAPEUTICS, INC.

Health Technology

IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

Aziende private6

Electronic Technology

Technology Services

Technology Services

Commercial Services

Health Technology

Finance

Vedi le connessioni aziendali